David Joel Mapes, PA-C

David Mapes practices at Edgar S. Macias, M.D., Inc in Fresno, California.

David Mapes' NPI, 1427428010, was assigned on September 25, 2015. David Mapes holds California license 52822.

David Mapes' primary practice is Edgar S. Macias, M.D., Inc, at 7115 N Chestnut Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 431-2397.

David Mapes' primary practice is Edgar S. Macias, M.D., Inc in Fresno, California. The medical group on file is Vituity. Dmand AI also links David Mapes to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Mapes practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is David Mapes' primary specialty in the NPI Registry, under taxonomy code 363A00000X. David Mapes is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). David Mapes is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions David Mapes treats.

CMS data shows 817 Medicare services from David Mapes across 11 procedure codes in 2024, for 212 Medicare patients. Medicare paid $38,892 for them. Every service was in an office.

CMS counts 212 Medicare patients who saw David Mapes in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Mapes' median patient age at 56, with 39% women.

In 2024, David Mapes wrote 811 Medicare Part D claims for 193 patients. 84% of them were for generic drugs. CMS names the drug for 661 of them, across 15 drugs with 11 or more claims each, at $206,109 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for David Mapes for performance year 2024, reported as part of a group. David Mapes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 150 general payments to David Mapes from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 44% of the total. Arcutis Biotherapeutics, Inc. paid the most, $4,741.

David Mapes is a member of AAPA.